ERBB2 and breast neoplasm: The results revealed that the NPs reduced the viability rate and increased the number of early apoptotic HER2+ breast tumor cells in a trend similar to that obtained with equivalent concentrations of free PTX, suggesting that the loading into PDA-NPs does not affect the pharmacological activity of the tested drug.